Computational tool developed to predict immunotherapy outcomes for patients with metastatic breast cancer
Using computational tools, researchers have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.
Read Original Article: Computational tool developed to predict immunotherapy outcomes for patients with metastatic breast cancer »
